<DOC>
	<DOCNO>NCT03089983</DOCNO>
	<brief_summary>The purpose study conduct empiric study tuberculosis ( TB ) among prison inmate history opioid dependence . This include : ) comprehensive TB diagnostic study ( symptom screening , chest x-ray , tuberculin skin test , acid-fast bacillus smear , Gene Xpert , sputum culture ) determine best practice screen HIV+ HIV- prisoner ; b ) A RCT latent TB infection prevention strategy among HIV+ HIV- prisoner high prevalence hepatitis C ( HCV ) use standard 40-week daily isoniazid ( 40H ) v short-course weekly isoniazid + rifapentine ( 12HR ) ; c ) 3-arm preference trial compare post-release TB treatment completion patient opioid agonist treatment ( methadone v naltrexone implant ) v opioid agonist treatment patient treat active latent TB transition community . Investigators also use data , publicly available data complete agent-based model comparative cost-effectiveness various TB screen treatment strategy among prisoner , upon community transition post-release prison .</brief_summary>
	<brief_title>Addiction , HIV Tuberculosis Malaysian Criminal Justice Settings</brief_title>
	<detailed_description>Part A : All newly admit prisoner ( 80-120 new inmate admission day ) undergo complete assessment , include brief exam mandatory rapid HIV test prison medical unit . Each prisoner wait evaluate invited participation TB screening activity ( currently part standard care ) . If verbally assent want learn group session , names ID record invite informed consent privately , follow brief survey , WHO symptom assessment , tuberculin skin testing ( TST ) read 72 hour , sputum induction 2 consecutive morning AFB smear , TB culture ( result back 6-8 week use BACTEC MGIT 960 liquid culture gold standard ) , point-of care ( POC ) Gene Xpert . Each person phlebotomy HBV HCV Ab , LFTs , HIV+ , CD4 test ( POC use Alere™ ) . For CD4 &lt; 50 , undergo POC low-cost , urinary TB-LAM lateral flow testing ( sensitivity=67 % ) ( Alere™ Determine ) identify disseminate TB . Additional demographic , drug use , TB risk also assess along prison data ( release date , previous incarceration , type offense ) . Participants undergo CXR testing . A TB specialist review patient result , ensure patient suspect TB initiate treatment . All suspect confirmed case active TB case HIV+ prisoner ART initiate 2 week TB treatment initiation ( CNS TB suspect ) CD4 &lt; 50 within 8 week others . Part B : All HIV+ prisoner latent TB infection ( LTBI ) ( TST reaction 10 mm great ) part A ask participate Part B. Enrolled participant undergo block stratify randomization , stratify three factor : ) CD4 &lt; 350 ; b ) HCV Ab status ; c ) ART status . After randomization allocation 12HR 40H , participant provide 12HR weekly ( 12 week ) INH daily ( 26 week ) directly observe therapy . Every 4 week , patient monitor AST/ALT adverse side effect . Premature treatment discontinuation occur DAIDS Grade 4 toxicity patient refusal continue . Part C : All HIV+ HIV-prisoners active LTBI meet pre-incarceration DSM-V criterion opioid dependence require transitional treatment active latent TB infection approach . If TB patient &gt; 3 month remain complete TB treatment , expect discharge home completing treatment ( 6 month active TB 26 week INH ) , eligible ; among HIV+ patient , active TB incidence 16 % annually LTBI prevalence 84 % . All HIV+ patient active TB receive PCP prophylaxis , LTBI CD4 &lt; 200 . Because previous study document negative attitude opioid agonist maintenance therapy ( OAT ) PWIDs Malaysia ( include prisoner ) readiness treatment may high , investigator enroll participant preference trial allow patient choose preferred OAT ( MMT , NTX implant , OAT ) help share decision-making aid . Because preference may change good informed , inform risk benefit OAT ask see preference change . Those prefer OAT , follow post-release monthly interview . Using previously describe procedure , MMT allocate participant initiate MMT immediately target dose &gt; 80mg ( n.b . Cytochrome P450 induction rifampin ART likely complete MMT initiate , make opioid withdrawal precipitation unlikely ) . For participant choose NTX , receive implant 7-10 day release . Consented participant undergo detailed baseline assessment administer use computer-assisted survey instrument ( CASI ) private research room guidance research assistant ( RA ) . Using procedure recently complete RCT release prisoner , participant meet day release transition integrated Cure Care center post-release site ( one research sit ) undergo day-of-release interview facilitate familiarity team community . All participant , regardless OAT , complete monthly follow-up visit 6 month . MMT dispense Cure &amp; Care Center use previously describe protocols team . The NTX implant replace UM Medical Center 90 day . At monthly visit , patient assess adverse side effect , drug/alcohol use , ART TB medication adherence use visual analogue scale ( VAS ) . TB , HIV substance abuse treatment outcome assess . All participant maintain OAT study completion .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Rifapentine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Inclusion Criteria ( part A ) : Age ≥ 18 year Newly admit inmate Kajang Prison Inclusion Criteria ( part B ) : Age ≥ 18 year HIV1 seropositivity Confirmed LTBI ( TST ≥ 5mm HIV+ ; TST ≥ 10 mm HIV ) Meets DSMV criterion opioid dependence &gt; 9 month release ( ensure treatment completion prison ) AST/ALT &lt; 3x upper limit normal Inclusion Criteria ( part C ) : Age ≥ 18 year Confirmed active ( chest Xray laboratory ) LTBI ( TST ≥ 5mm HIV+ ; TST ≥ 10 mm HIV ) Meets DSMV criterion opioid dependence &lt; 3 month release , &gt; 3 month TB treatment remain . Living Klang Valley release ( within 25 km community research site ) AST/ALT &lt; 5x upper limit normal Malaysian citizen ( nonMalaysians eligible receive standard care ) Unable provide inform consent On protease inhibitor Women pregnant plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>prison</keyword>
</DOC>